Altruist Biologics' Integrated CMC Platform Supports NMPA Acceptance of NDA for Localized Manufacturing of Multinational Client's Biologic

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Altruist-Biologics

More Like This

PR Newswire associated0

Altruist Biologics' Suzhou Site Receives EMA GMP Certification, Enabling Product Commercialization for the European Market

PR Newswire associated0

Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License

PR Newswire associated0

Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA

PR Newswire associated0

Altruist Biologics' Hangzhou Antibody-Drug Conjugate Facility Receives Provincial Regulatory Approval for Segmented Production

PR Newswire associated0

Altruist Biologics Completes First Commercial PPQ Campaign of its 20,000L Production Line at the Hangzhou Site

PR Newswire associated0

Altruist Biologics Launches Altru-CON™ High-Concentration Formulation Platform to Accelerate Biologics Development

PR Newswire associated0

WuXi Biologics at Festival of Biologics Basel 2026: Turning Scientific Complexity into Commercial Certainty

Business Wire logo

AGC Biologics Honored by Customers and Industry Leaders for Excellence in Contract Development and Manufacturing